BBVA USA Bancshares’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$759K Buy
5,045
+1,161
+30% +$184K 0.04% 341
2020
Q4
$589K Hold
3,884
0.03% 364
2020
Q3
$526K Hold
3,884
0.03% 350
2020
Q2
$530K Sell
3,884
-136
-3% -$17.3K 0.03% 355
2020
Q1
$433K Sell
4,020
-92
-2% -$10.6K 0.03% 350
2019
Q4
$495K Buy
+4,112
New +$459K 0.03% 376
2019
Q3
Sell
-4,020
Closed -$439K 439
2019
Q2
$439K Hold
4,020
0.03% 387
2019
Q1
$449K Buy
4,020
+300
+8% +$32.9K 0.03% 376
2018
Q4
$359K Hold
3,720
0.03% 390
2018
Q3
$454K Hold
3,720
0.03% 403
2018
Q2
$409K Hold
3,720
0.03% 403
2018
Q1
$397K Hold
3,720
0.03% 407
2017
Q4
$397K Hold
3,720
0.03% 405
2017
Q3
$414K Hold
3,720
0.03% 399
2017
Q2
$384K Hold
3,720
0.03% 414
2017
Q1
$364K Hold
3,720
0.02% 417
2016
Q4
$329K Hold
3,720
0.02% 444
2016
Q3
$359K Hold
3,720
0.03% 418
2016
Q2
$319K Hold
3,720
0.02% 417
2016
Q1
$323K Hold
3,720
0.02% 422
2015
Q4
$420K Hold
3,720
0.03% 361
2015
Q3
$376K Hold
3,720
0.03% 356
2015
Q2
$458K Hold
3,720
0.03% 372
2015
Q1
$426K Hold
3,720
0.02% 425
2014
Q4
$376K Hold
3,720
0.02% 446
2014
Q3
$339K Hold
3,720
0.02% 453
2014
Q2
$319K Hold
3,720
0.01% 475
2014
Q1
$293K Hold
3,720
0.01% 462
2013
Q4
$282K Hold
3,720
0.01% 463
2013
Q3
$260K Hold
3,720
0.01% 452
2013
Q2
$216K Buy
+3,720
New +$215K 0.01% 467

Other funds holding IBB

BBVA USA Bancshares's IBB Position: Q1 2021 in Review

BBVA USA Bancshares increased its iShares Biotechnology ETF (IBB) stake by 30% in Q1 2021, buying an estimated $184K and bringing the position to 5,045 shares worth $759K. The position accounts for 0.04% of the portfolio, ranked #341.

BBVA USA Bancshares first reported a position in IBB in Q2 2013 and has held it in 31 quarters since. 845 funds tracked by Wall St. Rank hold IBB as of Q1 2021.

  • BBVA USA Bancshares held 5,045 shares of iShares Biotechnology ETF worth $759K as of Q1 2021.
  • BBVA USA Bancshares bought 1,161 iShares Biotechnology ETF shares in Q1 2021, an estimated $184K.
  • iShares Biotechnology ETF made up 0.04% of BBVA USA Bancshares's portfolio in Q1 2021, its #341 holding.
  • BBVA USA Bancshares first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 31 quarters since.
  • 845 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2021.

Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.